Gemmus Pharma to Present Details on New Host-Based Approach to Infectious Disease/Flu Therapies at the Biotechnology Industry Organization (BIO) Investor Forum, San Francisco on October 8th
10/7/2013 7:41:49 AM
Gemmus Pharma, a biotechnology company developing improved treatments for infectious diseases, will present data at this year’s BIOInvestor Forum. The talk titled “GP1681: A New Host-targeted Influenza Therapy”, will be given by Daryl Faulds, Ph.D., Co-founder and CEO of Gemmus, on Tuesday October 8, at 8:45 am. The BIOInvestor Forum will be held at the Palace Hotel, San Francisco.
Help employers find you! Check out all the jobs and post your resume.